Rainbow Childrens Medicare share news, announcements and annual reports
NSE: RAINBOWBSE: 543524Healthcare ServicesSmall Cap
Rainbow Childrens Medicare Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2022 · Issue price ₹542
Last close ₹1,196.80down ₹8.00 (0.66%)BSE ₹1,198.00
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,204.80.
29 Oct: open ₹1,204.90, high ₹1,241.50, low ₹1,193.10
52-week range of traded prices to 29 Oct 2026
₹1,084.00Low, 23 Mar 2026₹1,610.00High, 5 Aug 2026
- Next results date: the board meets on 31 Oct 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹12,155 Cr481st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 42.59
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 7.38
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.29%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 25.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,07,01752.3% delivered
Rainbow Childrens Medicare has 290 announcements on record, routine notices left out; 2 in the 30 days to 30 Oct 2026, the latest on 23 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Rainbow Childrens Medicare quarterly results
Oct31Sat
The board meets on 31 Oct 2026 to consider financial results and other business matters
Notice filed 23 Oct 2026
Rainbow Childrens Medicare annual reports, presentations and earnings calls
The company's own documents, latest first.Rainbow Childrens Medicare financials, year by year
Annual reports5
- Annual report, year to Mar 20266 Jul 2026
- Annual report, year to Mar 202513 Jun 2025
- Annual report, year to Mar 20248 Jul 2024
- Annual report, year to Mar 20237 Jun 2023, a zip file
- Annual report, year to Mar 202224 Aug 2022, a zip file
Investor presentations19
- Investor Presentation30 Jul 2026
- Investor Presentation23 May 2026
- Investor Presentation28 Jan 2026
- Investor Presentation13 Nov 2025
- Investor Presentation26 Jul 2025
14 earlier presentations
- Investor Presentation24 May 2025
- Investor Presentation9 Feb 2025
- Investor Presentation27 Oct 2024
- Investor Presentation13 Aug 2024
- Investor Presentation19 May 2024
- Investor Presentation24 Jan 2024
- Investor Presentation30 Oct 2023
- Investor Presentation7 Aug 2023
- Investor Presentation14 May 2023
- Investor Presentation9 Feb 2023
- (the Listing Regulations), please find attached herewith Earnings Presentation of the Company on Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2022, which the Company proposes to share with analysts/ investors.We request you to kindly take the same on record.3 Nov 2022
- Please find herewith a revised earnings presentation on unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2022. The presentation shared earlier carried an error on slide 17 (titled: Restated consolidated statement of profit and loss), where the title headings for periods have been interchanged. The same has been rectified in copy attached herewith.8 Aug 2022
- Please find attached herewith Earnings Presentation of the Company on Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2022, which the Company proposes to share with analysts/ investors.8 Aug 2022
- Investor Presentation27 May 2022
Earnings calls35
- Transcript4 Aug 2026
- Link of Recording31 Jul 2026
- Transcript1 Jun 2026
- Link of Recording25 May 2026
- Transcript3 Feb 2026
30 earlier call documents
- Link of Recording29 Jan 2026
- Transcript20 Nov 2025
- Link of Recording14 Nov 2025
- Transcript4 Aug 2025
- Link of Recording28 Jul 2025
- Transcript31 May 2025
- Link of Recording26 May 2025
- Transcript15 Feb 2025
- Link of Recording10 Feb 2025
- Transcript4 Nov 2024
- Link of Recording28 Oct 2024
- Transcript21 Aug 2024
- Link of Recording14 Aug 2024
- Transcript27 May 2024
- Link of Recording21 May 2024
- Transcript1 Feb 2024
- Transcript7 Nov 2023
- Link of Recording31 Oct 2023
- Transcript16 Aug 2023
- Link of Recording8 Aug 2023
- Transcript22 May 2023
- Please note that the audio recording of the Company s Conference Call dated May 15, 2023 with the Investors/ Analysts for Q4 & FY23 is available on the Company's website at:https://www.rainbowhospitals.in/investor-relations/reports/RCML-Q4-and-FY23-Earnings-Audio.mp315 May 2023
- Please find enclosed the Transcript of the Investor call held on February 10, 2023, with regard to Financial Results of the Company for Q3 & 9M FY23.18 Feb 2023
- Please note that the audio recording of the Company s Conference Call dated February 10, 2023 with Investors/ Analysts for Q3 & 9M FY23 is available on the Company's website at:https://www.rainbowhospitals.in/investor-relations/reports/Earnings%20Call%20Audio%20Recording-%20Q3%20&%209M%20FY2023.mp310 Feb 2023
- Please find enclosed the Transcript of the Investor call held on November 4, 2022, with regard to Financial Results of the Company for Q2 & H1 FY23.11 Nov 2022
- Please note that the audio recording of the Company's Conference Call dated November 4, 2022 with Investors/ Analysts for Q2 & H1 FY23 is available on the Company's website at https://www.rainbowhospitals.in/investor-relations/reports/Earnings%20Call%20Audio%20Recording-%20Q2%20FY23.mp34 Nov 2022
- Please find enclosed the Transcript of the Investor call held on August 9, 2022, with regard to Financial Results of the Company for Q1 FY 23.17 Aug 2022
- Please note that the audio recording of the Company's Conference Call dated August 9, 2022 with Investors/ Analysts for Q1 - FY23 is available on the Company's website at https://www.rainbowhospitals.in/investorrelations/reports/Audio Recording Conference Call - Q1 FY23.mp39 Aug 2022
- Financial Results Webcast Transcript of the Company for Q4 & FY22.3 Jun 2022
- Please note that the recording of results webcast dated May 30, 2022 for Q4 & FY22 with Investors/ Analysts is available on the Company's website at https://www.rainbowhospitals.in/investor-relations/reports/RCML%20Webcast_30052022.mp430 May 2022
Rainbow Childrens Medicare share news and announcements
Newest first. Page 1 of 6.
Oct 2026
23 Oct · Analysts
Sep 2026
29 Sep · Rating
23 Sep · Options to purchase securities
23 Sep · Board meeting
16 Sep · General Updates
11 Sep · Analysts
Aug 2026
31 Aug · Management
25 Aug · Management
14 Aug · General Updates
Jul 2026
30 Jul · Options to purchase securities
30 Jul · Board meeting
30 Jul · Results
29 Jul · Business
29 Jul · Business
29 Jul · Business
29 Jul · Meeting
23 Jul · Analysts
23 Jul · General Updates
4 Jul · General Updates
Jun 2026
25 Jun · Options to purchase securities
May 2026
23 May · Options to purchase securities
23 May · Results
15 May · Analysts
4 May · Business
Apr 2026
8 Apr · Legal
The exchange asked on 7 Apr 2026
Mar 2026
Feb 2026
12 Feb · Analysts
Jan 2026
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 30 Sep 2026Credit ratingdown 3.91%−3.8 pts vs Nifty 500market median 0.0% · five sessions −7.1% (−6.9 pts vs Nifty 500) · volume 2.9× usual · delivery −3.1 pts against usual · The announcement
- 1 Sep 2026Board or managers changedup 2.24%+2.7 pts vs Nifty 500market median 0.0% · five sessions +3.9% (+5.2 pts vs Nifty 500) · volume 1.9× usual · delivery −9.0 pts against usual · The announcement
- 26 Aug 2026Board or managers changedup 0.10%+0.3 pts vs Nifty 500market median 0.0% · five sessions +0.1% (+1.2 pts vs Nifty 500) · volume 1.1× usual · delivery −22.2 pts against usual · The announcement
- 31 Jul 2026Resultsup 0.32%−0.1 pts vs Nifty 500market median −0.7% · five sessions +3.5% (+1.8 pts vs Nifty 500) · volume 2.3× usual · delivery −10.6 pts against usual · The announcement
- 25 May 2026Resultsdown 0.37%−1.6 pts vs Nifty 500market median −0.7% · five sessions +1.1% (+2.0 pts vs Nifty 500) · volume 1.0× usual · delivery −21.2 pts against usual · The announcement
- 29 Jan 2026Resultsdown 0.30%−0.5 pts vs Nifty 500market median −0.7% · five sessions −6.2% (−7.8 pts vs Nifty 500) · volume 0.8× usual · delivery −9.2 pts against usual · The announcement
- 14 Nov 2025Resultsdown 1.05%−1.1 pts vs Nifty 500market median −0.7% · five sessions −1.3% (−2.0 pts vs Nifty 500) · volume 0.9× usual · delivery +5.4 pts against usual · The announcement
- 18 Aug 2025Credit ratingup 0.39%−0.7 pts vs Nifty 500market median 0.0% · five sessions +1.6% (+0.2 pts vs Nifty 500) · volume 0.4× usual · delivery −12.3 pts against usual · The announcement
- 28 Jul 2025Resultsdown 1.00%−0.3 pts vs Nifty 500market median −0.7% · five sessions −1.9% (−0.4 pts vs Nifty 500) · volume 0.5× usual · delivery −11.9 pts against usual · The announcement
- 10 Jun 2025Board or managers changedup 0.53%+0.5 pts vs Nifty 500market median 0.0% · five sessions +2.9% (+3.9 pts vs Nifty 500) · volume 1.1× usual · delivery +7.8 pts against usual · The announcement
12 earlier announcements
- 26 May 2025Resultsup 0.38%−0.2 pts vs Nifty 500market median −0.7% · five sessions +3.7% (+3.6 pts vs Nifty 500) · volume 1.0× usual · delivery −14.7 pts against usual · The announcement
- 8 Jan 2025Credit ratingdown 1.36%−0.9 pts vs Nifty 500market median 0.0% · five sessions −10.2% (−6.3 pts vs Nifty 500) · volume 0.5× usual · delivery −2.5 pts against usual · The announcement
- 16 Dec 2024Board or managers changeddown 2.45%−2.4 pts vs Nifty 500market median 0.0% · five sessions −4.8% (−0.4 pts vs Nifty 500) · volume 0.3× usual · delivery +6.9 pts against usual · The announcement
- 28 Oct 2024Board or managers changedup 5.41%+4.7 pts vs Nifty 500market median 0.0% · five sessions +9.1% (+7.6 pts vs Nifty 500) · volume 4.3× usual · delivery +13.6 pts against usual · The announcement
- 14 Aug 2024Resultsup 1.59%+1.7 pts vs Nifty 500market median −0.7% · five sessions +0.6% (−2.4 pts vs Nifty 500) · volume 0.6× usual · delivery −13.1 pts against usual · The announcement
- 21 May 2024Dividenddown 4.74%−4.9 pts vs Nifty 500market median 0.0% · five sessions −10.1% (−11.8 pts vs Nifty 500) · volume 0.6× usual · delivery +7.0 pts against usual · The announcement
- 7 Dec 2023Credit ratingdown 0.70%−0.8 pts vs Nifty 500market median 0.0% · five sessions +0.6% (+0.2 pts vs Nifty 500) · volume 0.9× usual · delivery +9.0 pts against usual · The announcement
- 1 Jun 2023Board or managers changeddown 2.98%−2.9 pts vs Nifty 500market median 0.0% · five sessions −2.0% (−3.5 pts vs Nifty 500) · volume 1.9× usual · delivery −19.2 pts against usual · The announcement
- 15 May 2023Dividendup 2.05%+1.6 pts vs Nifty 500market median 0.0% · five sessions +5.5% (+5.9 pts vs Nifty 500) · volume 3.7× usual · delivery +0.7 pts against usual · The announcement
- 27 Apr 2023Credit ratingup 0.47%−0.1 pts vs Nifty 500market median 0.0% · five sessions +2.1% (−0.6 pts vs Nifty 500) · volume 0.3× usual · delivery −10.7 pts against usual · The announcement
- 9 Feb 2023Resultsdown 1.36%−1.4 pts vs Nifty 500market median −0.7% · five sessions −1.2% (−1.2 pts vs Nifty 500) · volume 1.9× usual · delivery −31.0 pts against usual · The announcement
- 30 May 2022Dividendup 0.62%−1.4 pts vs Nifty 500market median 0.0% · five sessions −4.7% (−6.2 pts vs Nifty 500) · delivery +0.4 pts against usual · The announcement
Rainbow Childrens Medicare results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Cash at the end of the period | At Mar 2026 | Consolidated | 13.64 | 33.89 | +148.5% | 23 May 2026 | 9 Oct 2026 |
| Cash at the end of the period | At Mar 2026 | Standalone | 0.39 | 17.28 | +4,330.8% | 24 May 2026 | 9 Oct 2026 |